Dexcel Pharma Technologies Ltd. is 10% Owner at Urovant Sciences Ltd. (UROV). They have made 4 open-market trades across 4 companies since 2017, most recently 2022-04-25.
CIK 0001720007
3 open-market purchases totalling $21.0M since 2017, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ROIV | BUY | 2022-04-22 | 2022-04-26 | $3.84 | $276K | -6.5% | +5.9% | +7.5% |
| NTEC | SELL | 2020-01-31 | 2020-02-04 | $0.31 | $508K | +0.1% | +3.6% | -14.6% |
| UROV | BUY | 2019-06-17 | 2019-06-19 | $8.31 | $151K | -5.1% | +3.9% | +15.5% |
| UROV | BUY | 2019-06-12 | 2019-06-14 | $8.06 | $177K | -2.4% | +19.6% | +18.9% |
| UROV | BUY | 2019-06-07 | 2019-06-11 | $8.29 | $115K | -6.7% | +6.1% | +20.7% |
| UROV | BUY | 2019-06-05 | 2019-06-06 | $8.02 | $52K | +4.5% | +2.1% | +13.9% |
| MYOV | BUY | 2019-06-04 | 2019-06-06 | $8.25 | $20.0M | -2.7% | -12.4% | -14.1% |
| UROV | BUY | 2019-05-30 | 2019-06-03 | $7.83 | $139K | +0.0% | +2.4% | +19.1% |
| UROV | BUY | 2019-05-20 | 2019-05-22 | $8.05 | $81K | +0.2% | +7.9% | +4.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.